Christopher I. Wright

Insider Reports History

Location: C/O Cyclerion Therapeutics, Inc., 245 First Street, 18 Th Floor, Cambridge, MA
Signature: /s/ Shantale Greenson, attorney-in-fact for Christopher I. Wright
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher I. Wright:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Alkermes plc.	Director	Ordinary Shares	23K	$730K	$31.71	Jun 8, 2025	Direct
Alkermes plc.	Director	Non Qualified Stock Option (Right to Buy)	13.5K			May 21, 2025	Direct
Alkermes plc.	Director	Restricted Stock Unit Award	0			Jun 8, 2025	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Christopher I. Wright

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ALKS	Alkermes plc.	Jun 8, 2025	3	-$25.1K	4	Jun 10, 2025	Director
ALKS	Alkermes plc.	May 31, 2025	3	-$58.9K	4	Jun 2, 2025	Director
ALKS	Alkermes plc.	May 21, 2025	2	$0	4	May 23, 2025	Director
ALKS	Alkermes plc.	Jun 29, 2024	3	-$35.3K	4	Jul 1, 2024	Director
ALKS	Alkermes plc.	Jun 8, 2024	3	-$19K	4	Jun 10, 2024	Director
ALKS	Alkermes plc.	May 31, 2024	8	$25.4K	4	Jun 4, 2024	Director
ALKS	Alkermes plc.	Jul 7, 2023	3	-$42.7K	4	Jul 10, 2023	Director
ALKS	Alkermes plc.	Jun 29, 2023	2	$0	4	Jun 30, 2023	Director
ALKS	Alkermes plc.	Jun 8, 2023	6	-$27.3K	4	Jun 12, 2023	Director
ALKS	Alkermes plc.	Jul 7, 2022	2	$0	4	Jul 8, 2022	Director
ALKS	Alkermes plc.	Jun 8, 2022	4	$0	4	Jun 10, 2022	Director
ALKS	Alkermes plc.	May 24, 2022	0	$0	3	May 31, 2022	Director